A study on bone mineral density in patients with Crohn's disease

Hepato-Gastroenterology

Volumn 55, Issue 88, 2008, Pages 2116-2120

  Oshima, Toshihiro ^a,b   Taira, Satoru ^a   Nonaka, Masaya ^a   Hayama, Yoshiki ^a   Yagi, Kenji ^a   Yukawa, Ikuko ^a   Koh, Mari ^a   Kondo, Mari ^a   Kawakami, Kohei ^a   Kawai, Takashi ^a   Miyaoka, Masaaki ^a   Sakai, Yoshihiro ^a   Moriyasu, Fuminori ^a   Matsuoka, Hiroaki ^a   Yamamoto, Kengo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Bone mineral density; Crohn's disease

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; OSTEOCALCIN; PREDNISOLONE;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE DURATION; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE ENDOSCOPY; INTESTINE RADIOGRAPHY; INTESTINE RESECTION; MALE; OSTEOPENIA; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; COLLAGEN TYPE I; CROHN DISEASE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDES; YOUNG ADULT;

EID: 60849084583     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Silvennoinen JA, Karttumen TJ, Niemela SE, Manelius JJ, Lehtola JK: A controlled study of bone Mineral density in patients with inflammatory bowel disease.Gut 1995; 37:71-76.
2. Pigot F,Roux C, Chaussade S, Hardelin D, Pelleter O, Montbrun TD-P, Listrat V, Dougados M, Couturier D, Amor B: Low bone mineral density in patients with inflammatory bowel disease.Dig Dis Sci 1992; 37:1396-1403.
3. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J: Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28:410-415.
4. Jahnsen J, Falch JA, Aadland E, Mowinckel P: Bone mineral density is redused in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study. Gut 1997; 40:313-319.
5. P Vestergaard, K Krogh, L Rejnmark, S Laurberg, L Mosekilde: Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000; 46:176-181.
6. Habtezion A, Silverberg MS, Parkes R, et al: Risk factors for bone density in Crohn's disease. Inflamm Bowel Dis 2002; 8:87.
7. Best W.R, Becktel J.M, Singleton J.W, et al? Development of a Crohn's disease activity index?Gastroenterology 1976; 70: 439-444.
8. Lennard-Jones JE: classification of inflammatory bowel disease. Scand J Gastroenterology 1989; 24:2-15.
9. Falch JA, Meyer HE. Bone mineral density measured by dual X-ray absorptiometry. Reference values in a Norwegian population. Tidsskr Nor Laegeforen 1996; 116:2299-302.
10. Robinson R.J, Azzawi FA, Iqbal S.J, Kryswckl. T, Almond L, Abrams K, and Mayberry J.F: Osteoporosis and Determinants of Bone density in Patients with Crohn's disease. Dig Dis Sci. 1998; 43:2500-2506.
11. Ardizzone S, Bollani S, Bettica P, et al: Altered bone metabolism in inflammatory bowel disease here is a difference between Crohn,s disease and ulcerative colitis. J Intern Med 2000; 247:63-70.
12. Lee SH, Kim HJ, Yang SK, et al. Decreased trabecular bone mineral density in newly diagnosed inflamaatory bowel disease patients in Korea. J Gastroenterol Hepatol 2000; 15: 512-518.
13. Schoon EJ, Blok BM, Geerling BJ, et al: Bone mineral density in patients with recently diagnosed inflammatory bone disease. Gastroenterology 2000;119:1203-1208.
14. Klaus J, Armberecht G, Steinkamp M, et al: High prevalence of osteoporotic vertebral flactures in patents with Crohn's disease. Gut 2002; 51:654-658.
15. Valentine JF, Sninky CA: Prevention and treatments of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94:878-883.
16. Compston JE, Judd D, Crawley EO, et al: Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28:410.
17. Siffildeen JS, Fedorak RN, Siminoski K, et al: Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 2004; 10:220.
18. Cohen D, Adachi JD: The treatment of glucocorticoid induced osteoporosis. J Steroid Biochem Mol Biol 2004; 88:337-349.
19. Canalis E: Mechanism of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2003; 15:454-457.
20. Dinca M, Fries W, Luisetto G et al: Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1292-1297.
21. Vakil N, Sparberg M: Steroid-related osteonecrosis in inflammatory bowel disease. Gastroenterology 1989; 96:62-67.
22. Abitbol V, Roux C, Chaussade S, et al: Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995;108:417-422.
23. Lin CL, Moniz C, Timothy JC, et al: Colitis causes bone loss in rats through suppression of formation. Gastroenterology 1996; 111:1263-1271.
24. Van Staa TP, Leufkens HG, Abenhaim L et al: Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000; 15:993-1000.
25. Schoon E, Muller MC, Vermeer C, Schurgers LJ, Brummer RJ, Stockbrugger RW: Low serum and bone vitamin K status in patients with longstanding Crohn's disease: Gut 2001; 48:473-477.
26. Vergnaud P, Garnero P, Meunier PJ, Breart G,, Kamihagi K and Delmas PD: Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women:the EPIDOS Study. J Clin Endocrinol Metab 1997; 82:719-724.